What is Rockwell Medical's market cap?

Rockwell Medical (RMTI) has a market capitalization of $27.6M and trades on NASDAQ.

Who are Rockwell Medical's competitors?

Rockwell Medical's key competitors include Baxter International Inc., Outset Medical, Inc. Common Stock, DaVita Inc., and others. These companies compete in similar markets and product categories.

Who does Rockwell Medical partner with?

Rockwell Medical's notable partners include DaVita, Inc., Innovative Renal Care, Fresenius Medical Care.

What subsidiaries does Rockwell Medical have?

Rockwell Medical's subsidiaries include Rockwell Transportation, Inc..

Where is Rockwell Medical headquartered?

Rockwell Medical is headquartered in United States of America and employs approximately 237 people. It has been publicly traded since 1998.

Rockwell Medical

RMTI

Rockwell Medical is a healthcare company specializing in the development, manufacturing, and distribution of hemodialysis products for patients with end-stage kidney disease.

Market cap

$27.63M-17.7%

Table of contents

Earnings

Q1 2026 report

May 7, 2026

Revenue$17.3MMiss by $618.5K EPS-$0.04Miss by $0.03

Read the full report

Next report

Aug 13, 2026 (In 2 weeks)

Revenue estimate$17.8M

EPS estimate-$0.24

Competitors

By market cap

DaVita$15.2B+38.1%

Baxter International$12.1B-17.6%

ICU Medical$4.0B+28.6%

Ardelyx$1.2B+22.1%

Akebia Therapeutics$343.4M-63.6%

Unicycive Therapeutics, Inc.$140.5M+134%

Outset Medical, Inc.$80.1M-75.0%

Rockwell Medical$27.6M-21.7%

By revenue growth

Ardelyx+18.2%

DaVita+6.7%

Baxter International+5.1%

Outset Medical, Inc.+2.0%

ICU Medical-10.9%

By net margin

DaVita5.65%-1.0pp

ICU Medical-0.317%+7.0pp

Baxter International-9.7%-4.5pp

Ardelyx-13.58%+9.9pp

Outset Medical, Inc.-63.65%+35.1pp

Profile

Rockwell Medical is a healthcare company specializing in the development, manufacturing, and distribution of hemodialysis products for patients with end-stage kidney disease. The company provides essential concentrates and dialysates used to remove toxins and balance electrolytes during dialysis treatments. Its core value proposition centers on being a reliable, high-quality supplier for outpatient clinics, hospitals, and home-based care settings globally.

Competitive position

A leading supplier of liquid bicarbonate concentrates in the U.S. with a significant manufacturing footprint and established relationships with the top five national dialysis providers.

GeographiesUnited States, Americas, Pacific Rim

Customer segmentsDialysis Service Providers, Hospitals, Healthcare Distributors

Business modelManufacturing, Direct-to-Clinic Distribution, Wholesale

SuppliersUSP grade chemical suppliers (sodium chloride, calcium chloride, etc.), Packaging manufacturers (drums, bottles, bags), Third-party logistics carriers

CustomersNational dialysis chains, University medical centers, Independent kidney centers, International medical distributors

CountryUnited States of America

Listed1998

Employees237.0

CEOMark Strobeck

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Websiterockwellmed.com

FilingsSEC EDGAR

Questions, answered.

What is Rockwell Medical's market cap?: Rockwell Medical (RMTI) has a market capitalization of $27.6M and trades on NASDAQ.
Who are Rockwell Medical's competitors?: Rockwell Medical's key competitors include Baxter International Inc., Outset Medical, Inc. Common Stock, DaVita Inc., and others. These companies compete in similar markets and product categories.
Who does Rockwell Medical partner with?: Rockwell Medical's notable partners include DaVita, Inc., Innovative Renal Care, Fresenius Medical Care.
What subsidiaries does Rockwell Medical have?: Rockwell Medical's subsidiaries include Rockwell Transportation, Inc..
Where is Rockwell Medical headquartered?: Rockwell Medical is headquartered in United States of America and employs approximately 237 people. It has been publicly traded since 1998.